Skip to main content
. 2022 Jun 20;127(6):1142–1152. doi: 10.1038/s41416-022-01886-4

Fig. 2. Cytokine secretome profile of Vemurafenib-resistant melanoma cell lines exhibit an increase in pro-tumour cytokines.

Fig. 2

a GO analysis based on differentially regulated cytokines on resistant melanoma cells. Each node shows an enriched GO term. Heatmap (OD mean) and cytokine expression graphic of b pro-tumour cytokine profile and c pro-angiogenic cytokine profile. Statistical analysis was performed using the Wilcoxson multiple comparison test.